文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Gut microbiota-mitochondrial crosstalk in obesity: novel mechanistic insights and therapeutic strategies with traditional Chinese medicine.

作者信息

Wen Lingmiao, Yang Kun, Wang Jiexin, Zhou Hang, Ding Weijun

机构信息

School of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, China.

出版信息

Front Pharmacol. 2025 Apr 22;16:1574887. doi: 10.3389/fphar.2025.1574887. eCollection 2025.


DOI:10.3389/fphar.2025.1574887
PMID:40331200
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12052897/
Abstract

Obesity rates are rising globally and have become a major public health issue. Recent research emphasizes the bidirectional communication between gut microbiota and mitochondrial function in obesity development. Gut microbiota regulates energy metabolism through metabolites that impact mitochondrial processes, such as oxidative phosphorylation, biogenesis, and autophagy. In turn, alterations in mitochondrial function impact microbiota homeostasis. Traditional Chinese medicine (TCM), which encompasses TCM formulas and the metabolites of botanical drugs, employs a holistic and integrative approach that shows promise in regulating gut microbiota-mitochondrial crosstalk. This review systematically explores the intricate interactions between gut microbiota and mitochondrial function, underscoring their crosstalk as a critical mechanistic axis in obesity pathogenesis. Furthermore, it highlights the potential of TCM in developing innovative, targeted interventions, paving the way for personalized approaches in obesity treatment through the precise modulation of gut microbiota-mitochondrial interactions, offering more effective and individualized therapeutic options.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f2c/12052897/568c8ba1f3ac/fphar-16-1574887-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f2c/12052897/65b1991657f3/fphar-16-1574887-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f2c/12052897/e2153fc38dd3/fphar-16-1574887-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f2c/12052897/568c8ba1f3ac/fphar-16-1574887-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f2c/12052897/65b1991657f3/fphar-16-1574887-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f2c/12052897/e2153fc38dd3/fphar-16-1574887-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f2c/12052897/568c8ba1f3ac/fphar-16-1574887-g003.jpg

相似文献

[1]
Gut microbiota-mitochondrial crosstalk in obesity: novel mechanistic insights and therapeutic strategies with traditional Chinese medicine.

Front Pharmacol. 2025-4-22

[2]
An overview of traditional Chinese medicine affecting gut microbiota in obesity.

Front Endocrinol (Lausanne). 2023

[3]
Convergent application of traditional Chinese medicine and gut microbiota in ameliorate of cirrhosis: a data mining and Mendelian randomization study.

Front Cell Infect Microbiol. 2023

[4]
The potential role of mitochondria in the microbiota-gut-brain axis: Implications for brain health.

Pharmacol Res. 2024-11

[5]
Novel Insight into the Modulatory Effect of Traditional Chinese Medicine on Cerebral Ischemia-Reperfusion Injury by Targeting Gut Microbiota: A Review.

Drug Des Devel Ther. 2025-1-10

[6]
Crosstalk between traditional Chinese medicine-derived polysaccharides and the gut microbiota: A new perspective to understand traditional Chinese medicine.

Phytother Res. 2022-11

[7]
Effect of traditional Chinese medicine on gut microbiota in adults with type 2 diabetes: A systematic review and meta-analysis.

Phytomedicine. 2021-7-15

[8]
Traditional Chinese medicine improved diabetic kidney disease through targeting gut microbiota.

Pharm Biol. 2024-12

[9]
The mitochondria-gut microbiota crosstalk - A novel frontier in cardiovascular diseases.

Eur J Pharmacol. 2025-7-5

[10]
Gut microbiota modulation with traditional Chinese medicine: A system biology-driven approach.

Pharmacol Res. 2019-9-18

引用本文的文献

[1]
Obesity-Mediated Inflammation and Its Influence on Inflammatory Bowel Disease: Pathophysiology, Clinical Impact, and Therapeutic Implications.

Biomolecules. 2025-8-18

本文引用的文献

[1]
Gut Microbiota Dysbiosis, Oxidative Stress, Inflammation, and Epigenetic Alterations in Metabolic Diseases.

Antioxidants (Basel). 2024-8-14

[2]
TFEB activator tanshinone IIA and derivatives derived from Salvia miltiorrhiza Bge. Attenuate hepatic steatosis and insulin resistance.

J Ethnopharmacol. 2024-12-5

[3]
Puerarin Modulates Hepatic Farnesoid X Receptor and Gut Microbiota in High-Fat Diet-Induced Obese Mice.

Int J Mol Sci. 2024-5-12

[4]
Mitochondrial dysfunction: mechanisms and advances in therapy.

Signal Transduct Target Ther. 2024-5-15

[5]
Shenling Baizhu San ameliorates non-alcoholic fatty liver disease in mice by modulating gut microbiota and metabolites.

Front Pharmacol. 2024-4-24

[6]
[Effect of Erchen Decoction on liver mitochondrial function by inhibiting mTORC1/SREBP1/CAV1 pathway in mice with high-fat diet].

Zhongguo Zhong Yao Za Zhi. 2024-2

[7]
Extract Inhibits Obesity by Promoting Thermogenesis and Mitochondrial Dynamics in High-Fat Diet-Fed Mice.

Int J Mol Sci. 2024-3-27

[8]
Unlocking potential: the role of the electron transport chain in immunometabolism.

Trends Immunol. 2024-4

[9]
Fecal microbiota transplantation ameliorates abdominal obesity through inhibiting microbiota-mediated intestinal barrier damage and inflammation in mice.

Microbiol Res. 2024-5

[10]
Microbiota-gut-brain axis and its therapeutic applications in neurodegenerative diseases.

Signal Transduct Target Ther. 2024-2-16

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索